Certified by Founder Lodge
Leaps by Bayer
Germany - Berlin
INVESTOR
1 Disclosed Funding Rounds $100,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Leaps by Bayer invests in paradigm-shifting advances in the life sciences – targeting the breakthroughs that could fundamentally change the world for the better. Our approach is making signif
| Company | Date | Round | Raised |
|---|---|---|---|
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
 NewLeaf Symbiotics, Inc. |
December, 21 ,2023 | Series D | $45,000,000 |
 NextPoint Therapeutics, Inc. |
February, 15 ,2024 | Series B | $42,500,000 |
 9amHealth |
February, 21 ,2024 | Series A | $9,500,000 |
 Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
Wildcat Discovery Technologies
OncoResponse
ResearchHub
DNTOX
OTPLESS | $3,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
Aeropay | $20,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
